Cash on Hand for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported cash and short-term investments is $1.43B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

RMD
Currently viewingCash on HandSwitch metric
Latest period
$1.43B
YoY change
+407.4%
5Y CAGR
+21.2%
Peak year (2025)
$1.21B
Latest annual
$1.21B
Cash on Hand history chart for ResMed (RMD) from 1993 to 2025
Cash on Hand history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $1.21B | +407.4% | ||
| 2024 | $238.36M | +4.6% | ||
| 2023 | $227.89M | -16.7% | ||
| 2022 | $273.71M | -7.3% | ||
| 2021 | $295.28M | -36.2% | ||
| 2020 | $463.16M | +214.8% | ||
| 2019 | $147.13M | -22.0% | ||
| 2018 | $188.70M | -77.0% | ||
| 2017 | $821.93M | +12.4% | ||
| 2016 | $731.43M | +2.0% | ||
| 2015 | $717.25M | -20.8% | ||
| 2014 | $905.73M | +3.4% | ||
| 2013 | $876.05M | +8.2% | ||
| 2012 | $809.54M | +10.1% | ||
| 2011 | $735.27M | +50.4% | ||
| 2010 | $488.78M | +17.6% | ||
| 2009 | $415.65M | +29.5% | ||
| 2008 | $321.08M | +15.6% | ||
| 2007 | $277.74M | +26.5% | ||
| 2006 | $219.54M | +54.4% | ||
| 2005 | $142.19M | +0.9% | ||
| 2004 | $140.93M | +16.4% | ||
| 2003 | $121.02M | +30.4% | ||
| 2002 | $92.84M | -9.6% | ||
| 2001 | $102.75M | +367.8% | ||
| 2000 | $21.96M | +31.5% | ||
| 1999 | $16.70M | +7.7% | ||
| 1998 | $15.50M | +70.3% | ||
| 1997 | $9.10M | +65.5% | ||
| 1996 | $5.50M | +66.7% | ||
| 1995 | $3.30M | -10.8% | ||
| 1994 | $3.70M | +117.6% | ||
| 1993 | $1.70M | — |
Cash on Hand values are taken from ResMed's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
ResMed (RMD) most recent annual cash and short-term investments stands at $1.21B (2025) – surged 407.4% year-over-year.
Looking at the 2020–2025 (5 years) stretch, ResMed cash and short-term investments compounded at +21.2% per year, sustaining 2 straight years of year-over-year growth.
Across the available history, cash and short-term investments reached its high of $1.21B in 2025 and its low of $1.70M in 1993.
Within Healthcare, ResMed (RMD) ranks 9th among 8 peers we track. The peer median for cash and short-term investments is $11.85B.
ResMed Cash on Hand by Year
ResMed Cash on Hand 2025: $1.21B
ResMed cash and short-term investments in 2025 was $1.21B, surged 407.4% from 2024. This figure represents the highest annual value in the available history.
ResMed Cash on Hand 2024: $238.36M
ResMed cash and short-term investments in 2024 was $238.36M, edged up 4.6% from 2023.
ResMed Cash on Hand 2023: $227.89M
ResMed cash and short-term investments in 2023 was $227.89M, declined 16.7% below 2022.
ResMed Cash on Hand 2022: $273.71M
ResMed cash and short-term investments in 2022 was $273.71M, declined 7.3% below 2021.
ResMed Cash on Hand 2021: $295.28M
ResMed cash and short-term investments in 2021 was $295.28M.
See more financial history for ResMed (RMD).
Sector peers — Cash on Hand
Companies in the same sector as ResMed, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is ResMed's cash and short-term investments?
- Latest reported cash and short-term investments for ResMed (RMD) is $1.43B (period ending December 31, 2025).
How has ResMed cash and short-term investments changed year-over-year?
- ResMed (RMD) cash and short-term investments changed +407.4% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed cash and short-term investments?
- ResMed (RMD) cash and short-term investments compound annual growth rate is +21.2% over the most recent 5 years available.
When did ResMed cash and short-term investments hit its highest annual value?
- ResMed cash and short-term investments reached its highest annual value of $1.21B in 2025.
What was ResMed cash and short-term investments in 2024?
- ResMed (RMD) cash and short-term investments in 2024 was $238.36M.
What was ResMed cash and short-term investments in 2025?
- ResMed (RMD) cash and short-term investments in 2025 was $1.21B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.